Fate Therapeutics (FATE) Short-term Investments (2016 - 2026)
Fate Therapeutics' Short-term Investments was $121.34 million in Q2 2026, down 33.2% from $181.58 million a year earlier and down 10.3% from the prior quarter.
Fate Therapeutics (FATE) Short-term Investments (2016 - 2026) Analysis & Trends
At the end of FY2025, Short-term Investments at Fate Therapeutics came in at $157.03 million, down 35.4% from FY2024.
- Short-term Investments has now declined for four consecutive years, with a five-year compound annual growth rate of -13.0% (FY2020 to FY2025).
- In earlier years, Short-term Investments was $243.01 million in FY2024 (-11.1%), $273.31 million in FY2023 (-27.1%), $374.89 million in FY2022 (-22.3%) and $482.33 million in FY2021 (+52.8%).
- The Q2 2026 figure marks the lowest quarterly Short-term Investments since Q2 2020.
- Compared with a year earlier, Short-term Investments has declined for 18 straight quarters, with an average decline of 27.3% over the last eight quarters.
- The best year-over-year quarter for Short-term Investments over five years was Q3 2021 (growth of 293.4%); the worst was Q2 2023 (a decline of 35.5%).
- Per Business Quant data, FATE's Short-term Investments in the three quarters before Q2 2026 was $135.25 million (Q1 2026), $157.03 million (Q4 2025) and $174.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Fate Therapeutics | 251.03 Mn | 97.23 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 121.34 Mn |
| Mar 31, 2026 | 135.25 Mn |
| Dec 31, 2025 | 157.03 Mn |
| Sep 30, 2025 | 174.80 Mn |
| Jun 30, 2025 | 181.58 Mn |
| Mar 31, 2025 | 195.51 Mn |
| Dec 31, 2024 | 243.01 Mn |
| Sep 30, 2024 | 259.01 Mn |
| Jun 30, 2024 | 267.96 Mn |
| Mar 31, 2024 | 262.22 Mn |
| Dec 31, 2023 | 273.31 Mn |
| Sep 30, 2023 | 316.40 Mn |
| Jun 30, 2023 | 331.13 Mn |
| Mar 31, 2023 | 366.88 Mn |
| Dec 31, 2022 | 374.89 Mn |
| Sep 30, 2022 | 423.04 Mn |
| Jun 30, 2022 | 513.58 Mn |
| Mar 31, 2022 | 509.03 Mn |
| Dec 31, 2021 | 482.33 Mn |
| Sep 30, 2021 | 549.52 Mn |
Fate Therapeutics Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=FATE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "FATE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=FATE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();